• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[无可用内容]。

[Not Available].

作者信息

Medhioub Mouna, Chtourou Lassaad, Kchaou Mehdi, Khsiba Amal, Zakhama Mejda, Ben Ameur Wafa, Moalla Manel, Yacoub Haythem, Ayadi Shema, Bouchabou Bochra, Battikh Hajer, Zribi Meriem, Siala Nadia, Azouz Mohamed Moussadek, Amouri Ali, Abdelli Mohamed Nabil, Safer Leila, Bibani Norsaf, Ben Mustapha Nadia, Hammami Aya, Abdelwaheb Mehdi, Ennaifer Rym, Jomni Taieb, Fekhi Monia

机构信息

Department of Gastroenterology - Mohamed Taher Maamouri Hospital, Nabeul - Tunisia.

Department of Gastroenterology - Hédi Chaker Hospital, Sfax- Tunisia.

出版信息

Tunis Med. 2023 Aug-Sep;101(8-9):657-669.

PMID:38445398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12377340/
Abstract

Helicobacter pylori infection is the most common infectious disease worldwide. It is associated with duodenal and gastric ulcer disease and the risk of gastric neoplasia. The management of helicobacter pylori infection currently represents a real challenge for clinicians, given the ever-increasing rate of resistance of Helicobacter pyolori to various antibiotics. In this consensus document, we present recommendations adapted to the Tunisian context, including indications for the detection of helicobacter pylori infection, indications for the use of different diagnostic methods, and a therapeutic strategy for the management of Helicobacter pylori infection.

摘要

幽门螺杆菌感染是全球最常见的传染病。它与十二指肠和胃溃疡疾病以及胃癌发生风险相关。鉴于幽门螺杆菌对各种抗生素的耐药率不断上升，目前幽门螺杆菌感染的管理对临床医生来说是一项真正的挑战。在本共识文件中，我们提出了适用于突尼斯情况的建议，包括幽门螺杆菌感染检测的指征、不同诊断方法的使用指征以及幽门螺杆菌感染管理的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/85c205fe479b/capture11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/15537037dbc9/capture1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/186160f8aa85/capture2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/de0c5808aef8/capture3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/bb5d862a14b7/capture4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/1d3417208590/capture5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/85140bd705bc/capture6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/93f601168695/capture7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/3f6232f3a16d/capture8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/beb422649529/capture9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/73f73e2a55a8/capture10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/85c205fe479b/capture11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/15537037dbc9/capture1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/186160f8aa85/capture2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/de0c5808aef8/capture3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/bb5d862a14b7/capture4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/1d3417208590/capture5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/85140bd705bc/capture6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/93f601168695/capture7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/3f6232f3a16d/capture8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/beb422649529/capture9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/73f73e2a55a8/capture10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c7f/12377340/85c205fe479b/capture11.jpg

相似文献

1
[Not Available].[无可用内容]。
Tunis Med. 2023 Aug-Sep;101(8-9):657-669.
2
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.幽门螺杆菌阳性人群消化性溃疡疾病的根除治疗。
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5.
3
Helicobacter pylori and gastric or duodenal ulcer.幽门螺杆菌与胃或十二指肠溃疡。
Prescrire Int. 2016 Jan;25(167):18-23.
4
First regional consensus on the management of infection in the Middle East.中东地区关于感染管理的首个区域共识。
World J Gastroenterol. 2025 Jul 21;31(27):107138. doi: 10.3748/wjg.v31.i27.107138.
5
Eradication of for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT.根除幽门螺杆菌预防65岁以上成年人阿司匹林相关消化性溃疡出血：HEAT随机对照试验
Health Technol Assess. 2025 Aug;29(42):1-62. doi: 10.3310/LLKF7871.
6
Non-invasive diagnostic tests for Helicobacter pylori infection.幽门螺杆菌感染的非侵入性诊断测试。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
7
Gastric cancer risk after Helicobacter pylori eradication in gastritis and peptic ulcer: a retrospective cohort study in Japan.胃炎和消化性溃疡患者根除幽门螺杆菌后的胃癌风险：日本的一项回顾性队列研究
BMC Gastroenterol. 2025 Jul 1;25(1):463. doi: 10.1186/s12876-025-04034-3.
8
Tests for Helicobacter pylori infection: a critical appraisal from primary care.幽门螺杆菌感染检测：基层医疗的批判性评估
Fam Pract. 2000 Aug;17 Suppl 2:S12-20. doi: 10.1093/fampra/17.suppl_2.s12.
9
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.幽门螺杆菌根除与胃癌发病率的关系：系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
10
Helicobacter pylori eradication for the prevention of gastric neoplasia.根除幽门螺杆菌以预防胃部肿瘤
Cochrane Database Syst Rev. 2015 Jul 22;2015(7):CD005583. doi: 10.1002/14651858.CD005583.pub2.

引用本文的文献

1
Comparison of bismuth and concomitant therapy for eradication: a prospective, randomized clinical trial.铋剂与联合疗法根除幽门螺杆菌的比较：一项前瞻性随机临床试验。
Future Sci OA. 2025 Dec;11(1):2527539. doi: 10.1080/20565623.2025.2527539. Epub 2025 Jul 10.

本文引用的文献

1
Prevalence of resistance to clarithromycin in Tunisia.突尼斯对克拉霉素的耐药率
J Med Microbiol. 2022 Aug;71(8). doi: 10.1099/jmm.0.001561.
2
Treatment of infection in the presence of penicillin allergy.青霉素过敏时的感染治疗。
World J Gastroenterol. 2021 Nov 28;27(44):7661-7668. doi: 10.3748/wjg.v27.i44.7661.
3
Management of Helicobacter pylori infection in the pediatric age.儿童时期幽门螺杆菌感染的管理。
An Pediatr (Engl Ed). 2021 Nov;95(5):383.e1-383.e9. doi: 10.1016/j.anpede.2021.05.004. Epub 2021 Oct 9.
4
What Is New in Diagnosis. An Overview.诊断学的新进展。概述。
J Clin Med. 2021 May 13;10(10):2091. doi: 10.3390/jcm10102091.
5
resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community.2018 年欧洲的抗生素耐药性及其与社区抗生素消费的关系。
Gut. 2021 Oct;70(10):1815-1822. doi: 10.1136/gutjnl-2021-324032. Epub 2021 Apr 9.
6
[Helicobacter pylori: When to look for an infection and treat it in adults?].[幽门螺杆菌：成人何时应筛查感染并进行治疗？]
Rev Med Interne. 2021 Jul;42(7):482-491. doi: 10.1016/j.revmed.2020.11.012. Epub 2021 Feb 26.
7
AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review.AGA 临床实践更新：难治性幽门螺杆菌感染的管理：专家综述。
Gastroenterology. 2021 Apr;160(5):1831-1841. doi: 10.1053/j.gastro.2020.11.059. Epub 2021 Jan 29.
8
Polymerase chain reaction-based tests for detecting clarithromycin resistance in stool samples: A meta-analysis.基于聚合酶链反应检测粪便样本中克拉霉素耐药性的试验：一项荟萃分析。
World J Clin Cases. 2021 Jan 6;9(1):133-147. doi: 10.12998/wjcc.v9.i1.133.
9
Evidence-Based Guidelines for the Treatment of Infection in Korea 2020.2020 年韩国感染治疗循证指南。
Gut Liver. 2021 Mar 15;15(2):168-195. doi: 10.5009/gnl20288.
10
Rifabutin for the Treatment of Infection: A Review.利福布汀用于感染治疗的综述
Pathogens. 2020 Dec 28;10(1):15. doi: 10.3390/pathogens10010015.